Arkolith/Insider Trading/ATRA/Form 4

Hyllengren Eric J

InsiderAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed Apr 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 31, 2025Disposed to issuer(D)543—$0160
Mar 31, 2025Disposed to issuer(D)460—$00
Mar 31, 2025Disposed to issuer(D)2K—$00
Mar 31, 2025Disposed to issuer(D)9K—$03K
Mar 31, 2025Disposed to issuer(D)331—$00
Mar 31, 2025Disposed to issuer(D)262—$00
Mar 31, 2025Disposed to issuer(D)350—$00
Mar 31, 2025Disposed to issuer(D)381—$00
Mar 31, 2025Disposed to issuer(D)496—$00
Mar 31, 2025Disposed to issuer(D)154—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-001058) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML